TPG Capital-owned Par Pharmaceutical files for IPO-Reuters
Generic drugmaker Par Pharmaceutical Holdings Inc, owned by private equity firm TPG Capital, filed with U.S. regulators for an initial public offering of common stock, Reuters reported.
13 March 2015•2 mins read
